Beclomethasone dipropionate (inhalation)

Revision as of 21:12, 26 January 2010 by Apalmer (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Beclomethasone dipropionate (inhalation)
Clinical data
Pregnancy
category
Routes of
administration
Oral & nasal inhalation, topical
ATC code
Legal status
Legal status
  • AU: S2 (Pharmacy only)
  • UK: POM (Prescription only)
Pharmacokinetic data
BioavailabilityConverted to beclometasone-17-monopropionate (17-BMP) during absorption
Protein binding87% of 17-BMP to albumin and transcortin
MetabolismBy esterase enzymes found in most tissues
Elimination half-life2.8 hours
Excretion?
Identifiers
CAS Number
PubChem CID
DrugBank
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC28H37ClO7
Molar mass521.042 g/mol

WikiDoc Resources for Beclomethasone dipropionate (inhalation)

Articles

Most recent articles on Beclomethasone dipropionate (inhalation)

Most cited articles on Beclomethasone dipropionate (inhalation)

Review articles on Beclomethasone dipropionate (inhalation)

Articles on Beclomethasone dipropionate (inhalation) in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Beclomethasone dipropionate (inhalation)

Images of Beclomethasone dipropionate (inhalation)

Photos of Beclomethasone dipropionate (inhalation)

Podcasts & MP3s on Beclomethasone dipropionate (inhalation)

Videos on Beclomethasone dipropionate (inhalation)

Evidence Based Medicine

Cochrane Collaboration on Beclomethasone dipropionate (inhalation)

Bandolier on Beclomethasone dipropionate (inhalation)

TRIP on Beclomethasone dipropionate (inhalation)

Clinical Trials

Ongoing Trials on Beclomethasone dipropionate (inhalation) at Clinical Trials.gov

Trial results on Beclomethasone dipropionate (inhalation)

Clinical Trials on Beclomethasone dipropionate (inhalation) at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Beclomethasone dipropionate (inhalation)

NICE Guidance on Beclomethasone dipropionate (inhalation)

NHS PRODIGY Guidance

FDA on Beclomethasone dipropionate (inhalation)

CDC on Beclomethasone dipropionate (inhalation)

Books

Books on Beclomethasone dipropionate (inhalation)

News

Beclomethasone dipropionate (inhalation) in the news

Be alerted to news on Beclomethasone dipropionate (inhalation)

News trends on Beclomethasone dipropionate (inhalation)

Commentary

Blogs on Beclomethasone dipropionate (inhalation)

Definitions

Definitions of Beclomethasone dipropionate (inhalation)

Patient Resources / Community

Patient resources on Beclomethasone dipropionate (inhalation)

Discussion groups on Beclomethasone dipropionate (inhalation)

Patient Handouts on Beclomethasone dipropionate (inhalation)

Directions to Hospitals Treating Beclomethasone dipropionate (inhalation)

Risk calculators and risk factors for Beclomethasone dipropionate (inhalation)

Healthcare Provider Resources

Symptoms of Beclomethasone dipropionate (inhalation)

Causes & Risk Factors for Beclomethasone dipropionate (inhalation)

Diagnostic studies for Beclomethasone dipropionate (inhalation)

Treatment of Beclomethasone dipropionate (inhalation)

Continuing Medical Education (CME)

CME Programs on Beclomethasone dipropionate (inhalation)

International

Beclomethasone dipropionate (inhalation) en Espanol

Beclomethasone dipropionate (inhalation) en Francais

Business

Beclomethasone dipropionate (inhalation) in the Marketplace

Patents on Beclomethasone dipropionate (inhalation)

Experimental / Informatics

List of terms related to Beclomethasone dipropionate (inhalation)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Beclometasone dipropionate (INN modified) or beclomethasone dipropionate (USAN, former BAN), also referred to as beclometasone (INN), is a potent Class A glucocorticoid steroid drug. In the form of an inhaler (e.g. Becotide), a wide number of brands of which are available, it is used for the prophylaxis of asthma. As a nasal spray (e.g. Beconase, Vancenase), it is used for the treatment of rhinitis (e.g. hayfever) and sinusitis. In some instances it is used by oral pathologists in the treatment of unusually severe canker sores.

As a cream or ointment (trade name Propaderm) it is used to treat severe inflammatory skin disorders (e.g. eczema) unresponsive to less potent steroids, but is generally avoided in the treatment of psoriasis due to the risk of rebound on withdrawal.

Chemistry

It is a white to creamy-white, odorless powder which is very slightly soluble in water, very soluble in chloroform, and freely soluble in acetone and in ethanol.

Side effects

Occasionally it may cause a cough upon inhalation. Deposition on the tongue and throat may promote oral candidiasis which appears as a white coating, possibly with irritation.[1][2][3] This may usually be prevented by rinsing the mouth with water after using the inhaler. Other side effects may rarely include unpleasant taste, hoarseness or nasal congestion, pain or headache and visual changes. Allergic reactions rarely may occur.

As a steroid, it can also cause occurrences of retina detachments, by triggering Central Serous Retinopathy.

Footnotes

  1. Willey R, Milne L, Crompton G, Grant I (1976). "Beclomethasone dipropionate aerosol and oropharyngeal candidiasis". Br J Dis Chest. 70 (1): 32–8. PMID 1259918.
  2. Salzman G, Pyszczynski D (1988). "Oropharyngeal candidiasis in patients treated with beclomethasone dipropionate delivered by metered-dose inhaler alone and with Aerochamber". J Allergy Clin Immunol. 81 (2): 424–8. PMID 3339197.
  3. Fukushima C, Matsuse H, Tomari S, Obase Y, Miyazaki Y, Shimoda T, Kohno S (2003). "Oral candidiasis associated with inhaled corticosteroid use: comparison of fluticasone and beclomethasone". Ann Allergy Asthma Immunol. 90 (6): 646–51. PMID 12839324.

Template:Antidiarrheals, intestinal anti-inflammatory/anti-infective agents

Template:Asthma and copd rx Template:Corticosteroids

Template:WikiDoc Sources
de:Beclometason Template:SIB Template:WH Template:WS